Hims & Hers Health (HIMS) Consolidated Net Income (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Consolidated Net Income came in at -$92.1 million in Q1 2026, down 286.15% year-on-year from $49.5 million in Q1 2025, and down 547.14% quarter-over-quarter from $20.6 million in Q4 2025.

Hims & Hers Health (HIMS) Consolidated Net Income (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Consolidated Net Income across 8 years of filings, most recently posting -$92.1 million for Q1 2026.

  • Consolidated Net Income for Q1 2026 came in at -$92.1 million, down 286.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.2 million (down 108.05% YoY), and the FY2025 annual result was $128.4 million, up 1.85% from the prior year.
  • Consolidated Net Income came in at -$92.1 million for Q1 2026 at Hims & Hers Health, down from $20.6 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $75.6 million in Q3 2024 to a low of -$92.1 million in Q1 2026.
  • The 5-year median for Consolidated Net Income is $1.2 million (2023), against an average of $4.3 million.
  • Across the five-year window, Consolidated Net Income soared 1990.36% in 2024 and plunged 286.15% in 2026, its largest moves.
  • Hims & Hers Health's Consolidated Net Income stood at -$10.9 million in 2022, then soared by 111.41% to $1.2 million in 2023, then jumped by 1990.36% to $26.0 million in 2024, then declined by 20.84% to $20.6 million in 2025, then sank by 547.14% to -$92.1 million in 2026.
  • The last three Consolidated Net Income figures came in at -$92.1 million (Q1 2026), $20.6 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -114,733.81
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 52.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -92.12 Mn
Dec 31, 2025 20.60 Mn
Sep 30, 2025 15.77 Mn
Jun 30, 2025 42.51 Mn
Mar 31, 2025 49.49 Mn
Dec 31, 2024 26.03 Mn
Sep 30, 2024 75.59 Mn
Jun 30, 2024 13.30 Mn
Mar 31, 2024 11.13 Mn
Dec 31, 2023 1.25 Mn
Sep 30, 2023 -7.57 Mn
Jun 30, 2023 -7.16 Mn
Mar 31, 2023 -10.07 Mn
Dec 31, 2022 -10.91 Mn
Sep 30, 2022 -18.84 Mn
Jun 30, 2022 -19.68 Mn
Mar 31, 2022 -16.25 Mn
Dec 31, 2021 -31.16 Mn
Sep 30, 2021 -15.94 Mn
Jun 30, 2021 -9.15 Mn